Allianz partners with actor Christoph Waltz to create social media series “Start Making Cents” The six-part series simplifies financial and insurance topics in an entertaining and engaging format. It also aims to broaden the understanding of Allianz beyond insurance by highlighting its investment and asset management expertise. Munich, March 17th, 2023 – Allianz has teamed… Read More »
Experts predict that 2022 will bring a rise in multi-vector attacks and cybersecurity awareness training will “hit its limit” after a year of increasingly sophisticated email attacks targeting organisations and their supply chains London, UK – 21st December 2021 – Cybersecurity experts from Egress, the leading provider of intelligent email security, have shared their top… Read More »
Before the pandemic, 16-year-old Na’ryen Cayou had everything he needed. He had his own room. A partial scholarship to a boys’ prep school. A spot playing trombone in the marching band, performing in parades all over New Orleans. Then covid-19 blew through the Big Easy like a hurricane, washing away nearly everything that helped him… Read More »
Loading the player… International Men’s Health Week is recognized each year the week leading up to Fathers’ Day in an effort to heighten awareness of preventable health problems among men and boys and encourage early detection and treatment of disease. In honor of Men’s Health Week, Fathers’ Day and Juneteenth, theGrio spoke to Dr. Denrick… Read More »
There’s a secret that many women who swim regularly know. It’s that the longer you spend in a piece of Lycra, the less you care about what your body looks like. s more and more women have taken to the waves and to rivers and lakes all over the country, it’s not so much a… Read More »
After multiple regulatory setbacks on Bristol Myers Squibb’s lymphoma CAR-T drug Breyanzi caused investors headaches, the company on Friday scored its second cell therapy approval. The FDA endorsed Abecma—formerly known as idecabtagene vicleucel, or ide-cel—to treat adults whose multiple myeloma has progressed after at least four previous rounds of treatment. It’s the first CAR-T med approved in multiple myeloma and the first CAR-T in… Read More »